Neuron-specific enolase as a prognosticator in cardiac arrest patients: key considerations

Conflict of interest statement

The author declares no conflict of interest.

Author contributions

Sethuraman RM wrote, reviewed, and edited the paper.

Funding

None.

Ethical approval of studies and informed consent

Not applicable.

Acknowledgements

None.

References

[1] Sierakowska A, Niewiadomska E, Łabuda S, Bieniasiewicz A, Roszak M, Łabuz-Roszak B . Neuron-specific enolase as a biomarker for selected neurological and psychiatric disorders-a systematic review of the literature. Medicina (Kaunas). 2025; 61(10): 1831. doi: 10.3390/medicina61101831.

[2] Obling LER, Beske RP, Meyer MAS, et al. Prehospital high-dose methylprednisolone in resuscitated out-of-hospital cardiac arrest patients (STEROHCA): a randomized clinical trial. Intensive Care Med. 2023; 49(12): 1467-1478. doi: 10.1007/s00134-023-07247-w.

[3] Müller J, Bissmann B, Becker C, et al. Neuron-specific enolase (NSE) predicts long-term mortality in adult patients after cardiac arrest: results from a prospective trial. Medicines (Basel). 2021; 8(11): 72. doi: 10.3390/medicines8110072.

[4] Streitberger KJ, Leithner C, Wattenberg M, et al. Neuron-specific enolase predicts poor outcome after cardiac arrest and targeted temperature management: a multicenter study on 1,053 patients. Crit Care Med. 2017; 45(7): 1145-1151. doi: 10.1097/CCM.0000000000002335.

[5] Nolan JP, Sandroni C, Böttiger BW, et al. European Resuscitation Council and European Society of Intensive Care Medicine guidelines 2021: post-resuscitation care. Intensive Care Med. 2021; 47(4): 369-421. doi: 10.1007/s00134-021-06368-4.

[6] Kim YJ, Kim YH, Youn CS, et al. Different neuroprognostication thresholds of neuron-specific enolase in shockable and non-shockable out-of-hospital cardiac arrest: a prospective multicenter observational study in Korea (the KORHN-PRO registry). Crit Care. 2023; 27(1): 313. doi: 10.1186/s13054-023-04603-6.

[7] Vondrakova D, Kruger A, Janotka M, et al. Association of neuron-specific enolase values with outcomes in cardiac arrest survivors is dependent on the time of sample collection. Crit Care. 2017; 21(1): 172. doi: 10.1186/s13054-017-1766-2.

[8] Chung-Esaki HM, Mui G, Mlynash M, Eyngorn I, Catabay K, Hirsch KG . The neuron specific enolase (NSE) ratio offers benefits over absolute value thresholds in post-cardiac arrest coma prognosis. J Clin Neurosci. 2018; 57: 99-104. doi: 10.1016/j.jocn.2018.08.020.

[9] Babkina AS, Lyubomudrov MA, Golubev MA, Pisarev MV, Golubev AM . Neuron-specific enolase-what are we measuring?. Int J Mol Sci. 2024; 25(9): 5040. doi: 10.3390/ijms25095040.